Ekso Bionics Holdings, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
Ekso Update – What Ekso’s Latest Move Means For Your Money
Article By: Keith Fitzgerald
Friday, May 6, 2016 5:25 PM EDT
Uplistings and reverse splits for growing companies like Ekso are a fabulous development because they mean the company is taking the steps needed to attract not only more capital, but much bigger amounts of it.
In this article: EKSO
Read
Ekso Bionics Announces 1-For-7 Reverse Stock Split In Preparation For Proposed Uplisting To Nasdaq
Article By: NASDAQ GlobeNewswire
Wednesday, May 4, 2016 6:38 PM EDT
The company believes that it currently meets all of the listing requirements for listing the company’s common stock on the Nasdaq Capital Market other than the minimum trading price requirement.
In this article: EKSO
Read
Two Important Updates On Ekso Bionics Inc. And Consolidated Water Company
Article By: Keith Fitzgerald
Monday, February 29, 2016 1:29 PM EDT
One of Wall Street’s cardinal sins is a “set it and forget it” mentality. What I mean by that is there’s often a flurry of interest in specific stocks and then….nothing.
In this article: EKSO, CWCO
Read
Ekso Bionics – 33 Million Strides Taken To Corner A $2.1 Billion Market
Article By: Money Morning
Thursday, November 12, 2015 9:44 PM EDT
I've reviewed thousands of companies over the past 33 years in global markets, but none capture the imagination the way Ekso Bionics Holdings Inc. does.
In this article: BA, RWLK, EKSO
Read
ReWalk Robotics IPO Exoskeletons For The Disabled
Article By: IPO Candy
Friday, September 12, 2014 4:21 PM EDT
RWLK is an “opportunity stock” and positioning itself as the leader to allow paralyzed people to walk. But what about the competition? Ekso Bionics, Landauer, Amedica Corp., and K2M target the same area with different therapies that are worth looking at...
In this article: LDR, RWLK, EKSO, AMDA, KTWO
Read
All Posts

Latest Tweets for $EKSO

No tweets yet!

PARTNER HEADLINES